510(k) device
SofWave System
Sofwave Medical, Ltd. · Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption (OHV, Class II) · First FDA decision Nov 15, 2021, newest May 30, 2024Aesthetic skin, fat and body contouring
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
510(k) pathway
Device trials
15
Naming "SofWave"
MAUDE reports
20
Brand "SofWave", since 2015
PubMed studies
5
Mentioning "SofWave"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SofWave System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
- SofWave System510(k)
K240687 · Decided May 30, 2024 · 79 days after receipt
Device type: Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption (OHV) · General & Plastic Surgery
5 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower ExtremitiesLocal determinationIn effectL36690CGS Administrators, LLCUpdated Aug 28, 2026
- Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for TremorProposed local determinationProposedDL37421National Government Services, Inc.Updated Sep 18, 2025
- Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's DiseaseLocal determinationIn effectL37729Noridian Healthcare Solutions, LLCUpdated Sep 2, 2025
- Ultrasound, Soft Tissues of Head and NeckLocal determinationIn effectL34027First Coast Service Options, Inc.Updated Sep 18, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "SofWave", any status and sponsor, newest update first.
Sofwave Medical LTDNot on our public-company list
NCT07723664 · 30 participants (planned) · Start Jul 20, 2026 · Primary completion Jul 15, 2027
Device: SofWave · For: Facial Wrinkles; Jawline Contour; Skin Laxity
Sites: Houston, Texas
14 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SofWave", and for the whole product code for context.
This brand
20 reports: 1 malfunction, 18 injury, 0 death
Whole product code OHV
185 reports: 10 malfunction, 173 injury, 0 death
Newest reports for this brand
- SofwaveOther
MW6001609 · Received Aug 31, 2026 · Event dated Aug 18, 2026
Device type: Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption (OHV)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Bruise/Contusion; Scar Tissue; Skin Discoloration; Numbness; Blister; Localized Skin Lesion; Nodule; Swelling/ Edema
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "SofWave"[tiab]. The summary above synthesizes these.
- Ultrasound Therapy for the Skin.
Wong A, Lowery AS, Bloom JD · Facial Plast Surg Clin North Am · 2023Review
- A Computational Trial of Dermal Mechanotransduction in GLP-1 Receptor Agonist-Associated Premature Facial Ageing.
Rahman E, Webb WR, Carruthers JDA · Aesthetic Plast Surg · 2026Randomized Controlled Trial
- Efficacy and safety of high-intensity, high-frequency, non-focused ultrasound parallel beams for facial skin laxity.
Gold MH, Biron J · J Cosmet Dermatol · 2024Clinical Trial
- The efficacy and safety of the high-intensity parallel beam ultrasound device at the depth of 1.5ߙmm for skin tightening.
Hongcharu W, Boonchoo K, Gold MH · J Cosmet Dermatol · 2023
- The Efficacy and Safety of a Single Treatment of High-Intensity, High-Frequency, Non-Focused Ultrasound Parallel Beams for Facial Acne Scars in Asian Patients: A Preliminary Study.
Boonchoo K, Hongcharu W · J Cosmet Dermatol · 2025
Other devices of this type
Also filed under product code OHV.
- Ulthera® SystemUlthera, Inc. · De Novo 2026
- UltraShape SystemSyneron Medical, Ltd. · 510(k) 2016
- Ultrashape Power SystemSyneron Medical, Ltd. · 510(k) 2017
- Scizer (SC1-M410)Classys, Inc. · 510(k) 2023
- BeShape One DeviceBeshape Technologies , Ltd. · 510(k) 2023
- LIPOcelJeisys Medical, Inc. · 510(k) 2019
- Sofacia SystemSofwave Medical, Ltd. · 510(k) 2019
- Contour I V3.1 SystemSyneron Medical, Ltd. · 510(k) 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.